β2-Adrenergic receptor antagonists are not protective against spinal cord injury-induced bone loss.
It is demonstrated that while blocking β2-ARs is sufficient to reduce NE-driven osteoclastogenesis, excessive NE does not fully explain SCI-induced bone loss.